Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Bayer AG    BAYN   DE000BAY0017

BAYER AG

(BAYN)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
09/16/2019 09/17/2019 09/18/2019 09/19/2019 09/20/2019 Date
67.87(c) 66.85(c) 66.2(c) 66.9(c) 67.23 Last
1 723 227 2 452 669 1 879 907 2 288 769 7 164 452 Volume
-0.28% -1.50% -0.97% +1.06% +0.49% Change
More quotes
Financials (EUR)
Sales 2019 46 036 M
EBIT 2019 7 933 M
Net income 2019 3 131 M
Debt 2019 37 298 M
Yield 2019 4,25%
Sales 2020 47 625 M
EBIT 2020 9 202 M
Net income 2020 4 666 M
Debt 2020 34 719 M
Yield 2020 4,50%
P/E ratio 2019 21,3x
P/E ratio 2020 13,8x
EV / Sales2019 2,17x
EV / Sales2020 2,04x
Capitalization 62 388 M
More Financials
Company
Bayer is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Sales are distributed by product family as follows: - healthcare products (56.1%): pharmaceutical products (75.4% of net sales; intended for the prevention and treatment of... 
Sector
Pharmaceuticals
Calendar
09/19Presentation
More about the company
Surperformance© ratings of Bayer AG
Trading Rating : Investor Rating :
More Ratings
Latest news on BAYER AG
02:37aBAYER : data at ESMO 2019 highlights innovation in cancer research
PU
09/19Animal health sector aims to emulate Zoetis biotech leap
RE
09/19Biotech is going to the dogs - and big profits await
RE
09/17BAYER : Invests $20 Million in U.S.-Based Informed Data Systems
DJ
09/17BAYER : and Informed Data Systems Inc. to develop One Drop digital therapeutics ..
PU
09/11BAYER : opens application window for Grants4Traits™ and Grants4Biologicals..
PU
09/10BAYER : to reduce size of management board to five
RE
09/10BAYER : to Reduce Size of Management Board
DJ
09/10BAYER : reduces size of Board of Management from seven to five members
PU
09/10BAYER : launches latest fungicide innovation, iblon™ technology
PU
More news
Analyst Recommendations on BAYER AG
More recommendations
Stock Trading Strategies
BAYER - 01/07
The beginning of the move
BUY
More Stock Trading Analysis
Sector news : Pharmaceuticals - NEC
07:38aMERCK AND : Gets FDA OK For Expanded Pifeltro, Delstrigo Indications
DJ
07:13aELI LILLY AND : Gets CHMP Positive Opinion for Expanded Trulicity Label
DJ
07:08aREGENERON PHARMACEUTICALS : Sanofi Get Positive CHMP Opinion for Dupixent
DJ
09/19Microsoft Plans Board Changes -- Update
DJ
09/19MICROSOFT : Plans Board Changes
DJ
More sector news : Pharmaceuticals - NEC
Chart BAYER AG
Duration : Period :
Bayer AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BAYER AG
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 28
Average target price 78,94  €
Last Close Price 66,91  €
Spread / Highest target 83,8%
Spread / Average Target 18,0%
Spread / Lowest Target -42,1%
EPS Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Werner Wenning Chairman-Supervisory Board
Wolfgang U. Nickl Chief Financial Officer
Katharina Jansen Head-Science & Research
Hartmut Klusik Head-Human Resources, Technology & Sustainability
Sector and Competitors
1st jan.Capitalization (M$)
BAYER AG9.31%68 944
JOHNSON & JOHNSON1.05%343 382
ROCHE HOLDING LTD.16.27%243 639
MERCK AND COMPANY9.89%214 995
PFIZER-16.36%201 939
NOVARTIS15.60%198 194